206 related articles for article (PubMed ID: 21152675)
1. [Endogenous thrombin potential in practical use].
Wilkens M
Hamostaseologie; 2011 May; 31(2):88-93. PubMed ID: 21152675
[TBL] [Abstract][Full Text] [Related]
2. Standardization and clinical utility of thrombin-generation assays.
Berntorp E; Salvagno GL
Semin Thromb Hemost; 2008 Oct; 34(7):670-82. PubMed ID: 19085768
[TBL] [Abstract][Full Text] [Related]
3. Evolving techniques for monitoring clotting in plasma and whole blood samples.
Carr ME; Martin EJ
Clin Lab; 2004; 50(9-10):539-49. PubMed ID: 15481629
[TBL] [Abstract][Full Text] [Related]
4. Challenges in the laboratory analyses of bleeding disorders.
Chitlur M
Thromb Res; 2012 Jul; 130(1):1-6. PubMed ID: 22483776
[TBL] [Abstract][Full Text] [Related]
5. Thrombin generation testing for monitoring hemophilia treatment: a clinical perspective.
Salvagno GL; Berntorp E
Semin Thromb Hemost; 2010 Oct; 36(7):780-90. PubMed ID: 20978999
[TBL] [Abstract][Full Text] [Related]
6. Thrombin generation and coagulation factor activities: evaluation and comparison with the international normalized ratio.
Christensen TD; Jensen C; Larsen TB; Christiansen K; Sørensen B
Blood Coagul Fibrinolysis; 2009 Jul; 20(5):358-65. PubMed ID: 19417631
[TBL] [Abstract][Full Text] [Related]
7. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
[TBL] [Abstract][Full Text] [Related]
8. [Thrombinography: towards a globalization of coagulation tests].
Péters P; Gothot A
Rev Med Liege; 2009 Apr; 64(4):199-203. PubMed ID: 19514539
[TBL] [Abstract][Full Text] [Related]
9. [Thrombin generation test].
Espitia O; Fouassier M
Rev Med Interne; 2015 Oct; 36(10):690-3. PubMed ID: 26028157
[TBL] [Abstract][Full Text] [Related]
10. Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.
Couturaud F; Duchemin J; Leroyer C; Delahousse B; Abgrall JF; Mottier D;
Thromb Haemost; 2008 Jan; 99(1):223-8. PubMed ID: 18217158
[TBL] [Abstract][Full Text] [Related]
11. Thrombin Generation Assays (TGAs).
Salvagno GL; Berntorp E
Methods Mol Biol; 2017; 1646():515-522. PubMed ID: 28804851
[TBL] [Abstract][Full Text] [Related]
12. Increased thrombin generation and fibrinogen level after therapeutic plasma transfusion: relation to bleeding.
Schols SE; van der Meijden PE; van Oerle R; Curvers J; Heemskerk JW; van Pampus EC
Thromb Haemost; 2008 Jan; 99(1):64-70. PubMed ID: 18217136
[TBL] [Abstract][Full Text] [Related]
13. How to interpret and pursue an abnormal prothrombin time, activated partial thromboplastin time, and bleeding time in adults.
Kamal AH; Tefferi A; Pruthi RK
Mayo Clin Proc; 2007 Jul; 82(7):864-73. PubMed ID: 17605969
[TBL] [Abstract][Full Text] [Related]
14. Thrombin generation assessed as endogenous thrombin potential in patients with hyper- or hypo-coagulability.
Chantarangkul V; Clerici M; Bressi C; Giesen PL; Tripodi A
Haematologica; 2003 May; 88(5):547-54. PubMed ID: 12745274
[TBL] [Abstract][Full Text] [Related]
15. Effect of melagatran on prothrombin time assays depends on the sensitivity of the thromboplastin and the final dilution of the plasma sample.
Mattsson C; Menschiek-Lundin A; Wåhlander K; Lindahl TL
Thromb Haemost; 2001 Aug; 86(2):611-5. PubMed ID: 11522011
[TBL] [Abstract][Full Text] [Related]
16. Standardization of coagulation tests.
Opartkiattikul N
Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():79-85. PubMed ID: 10926265
[TBL] [Abstract][Full Text] [Related]
17. Thromboelastography in children with coagulation factor deficiencies.
Chitlur M; Warrier I; Rajpurkar M; Hollon W; Llanto L; Wiseman C; Lusher JM
Br J Haematol; 2008 Jun; 142(2):250-6. PubMed ID: 18492116
[TBL] [Abstract][Full Text] [Related]
18. Preserved clot formation detected by the Thrombodynamics analyzer in patients with cirrhosis.
Potze W; Adelmeijer J; Porte RJ; Lisman T
Thromb Res; 2015 May; 135(5):1012-6. PubMed ID: 25746364
[TBL] [Abstract][Full Text] [Related]
19. Method for in vitro analysis of nanoparticle thrombogenic properties.
Neun BW; Dobrovolskaia MA
Methods Mol Biol; 2011; 697():225-35. PubMed ID: 21116972
[TBL] [Abstract][Full Text] [Related]
20. A comprehensive model for the humoral coagulation network in humans.
Wajima T; Isbister GK; Duffull SB
Clin Pharmacol Ther; 2009 Sep; 86(3):290-8. PubMed ID: 19516255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
